Country Reports

France’s healthcare and life sciences sector enters 2026 with cautious momentum. With the annual budget finally making its way through the French parliament, stakeholders can look forward to the year ahead in Europe’s second-largest market with increased certainty. And, as this exclusive new report shows, there is plenty to be optimistic about. Healthcare & Life…

See Full Report

Latin America enters 2026 in a state of sharp contradiction. Healthcare and life sciences capabilities are expanding in scale and strategic relevance, even as political volatility and economic uncertainty remain structural features of the region. Recent geopolitical tensions and sanctions rhetoric have once again highlighted how exposed healthcare systems are to currency swings, procurement disruption,…

See Full Report

Switzerland stands as one of the world’s foremost life science hubs, combining scientific depth, industrial strength, and a uniquely collaborative ecosystem. The country hosts a powerful axis of biopharma, diagnostics, and advanced manufacturing stretching from Basel through Zurich, Zug and Rotkreuz, supported by global and regional headquarters, leading R&D centres, and an exceptional talent base.…

See Full Report

In the global health and life sciences landscape, Denmark has emerged as a small country with an outsized voice – not only through its scientific and industrial achievements, but also through its collaborative, values-based approach to health innovation and policymaking. As Denmark holds the presidency of the Council of the European Union for the remainder…

See Full Report

In the global pharmaceutical supply chain, one small Caribbean island punches far above its weight. The US jurisdiction of Puerto Rico – just 100 miles by 35 miles – out-exports every individual US state in biopharmaceuticals, shipping over USD 53 billion worth of medicines and medical devices annually to 120 countries. That’s more than twice…

See Full Report

Saudi Arabia is moving fast, thinking big and aiming high as it powers towards the goals set forth in its Vision 2030 national transformation plan. The astonishing pace and extent of change underway throughout the Kingdom is fuelling major progress within the realm of healthcare and life science. The Middle East’s largest country and its…

See Full Report

Mexico’s healthcare and life sciences sector is at a pivotal moment. As a country with deep manufacturing expertise, a rapidly evolving regulatory landscape, and a strategic position at the heart of North America, Mexico is both a regional powerhouse and a critical player in the global healthcare ecosystem. But with opportunity comes challenge, and 2025…

See Full Report

China’s position as one of the top global sources and recipients of biopharmaceutical innovation is inarguable. As the Year of the Dragon draws to a close, leading Chinese life sciences stakeholders remain undimmed in their commitment to the country and the myriad opportunities to bring breakthroughs to patients, both within China’s borders and beyond. Healthcare…

See Full Report

Switzerland stands tall as a global powerhouse in healthcare and life sciences, a nation where innovation and precision converge to shape the future of medicine. With its thriving biotech ecosystem, groundbreaking research, and advanced manufacturing capabilities, Switzerland remains the gold standard in Europe—punching far above its weight for a country of just 8.5 million. Home…

See Full Report

One year on from our last report on the healthcare and life sciences ecosystem in Hong Kong and the Greater Bay Area (GBA), a lot has changed. Major new collaborative infrastructure projects, including the Hong Kong-Shenzhen Innovation and Technology Park and the GBA Clinical Trial Institute, have made significant progress and promise to reshape the…

See Full Report

Under its overarching ‘Vision 2030’ economic diversification plan, Saudi is aiming to play a much greater regional and global role in everything from artificial intelligence to sport and, significantly, healthcare. Ambitious and wide-ranging transformation plans are in place to raise health span and deepen care coverage, while local and female participation in the workforce is…

See Full Report

Rising per capita GDP, enhanced purchasing power, and a surge in inward-bound FDI flows mean that the Indian economy is on its strongest footing in generations. India’s leading industries – notably its life science sector – are reaping the rewards and anticipating rapid market growth. The USD 65 billion Indian pharma market is predicted to…

See Full Report
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here